JAZZ vs OTIS · P/E 1988, rev $2.28B vs P/E 19, rev $7.42B
Jazz Pharmaceuticals PLC (JAZZ) versus Otis Worldwide Corp (OTIS) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Otis Worldwide Corp (OTIS) is a specialty industrial machinery company listed on NYSE.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported OTIS revenue for 2026-06-30 was $7.42B. Net income was $768.0M. OTIS currently screens at market cap $27.90B and trailing P/E 19.3.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. OTIS currently screens at market cap $27.90B and trailing P/E 19.3.
Not investment advice. Open the JAZZ and OTIS stock pages for the full models.
Not investment advice.